➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Merck
Dow
McKesson
Moodys

Last Updated: September 26, 2020

DrugPatentWatch Database Preview

DETROL Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Detrol, and when can generic versions of Detrol launch?

Detrol is a drug marketed by Upjohn and is included in two NDAs. There are three patents protecting this drug and two Paragraph IV challenges.

The generic ingredient in DETROL is tolterodine tartrate. There are twenty-three drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the tolterodine tartrate profile page.

Drug patent expirations by year for DETROL
Drug Prices for DETROL

See drug prices for DETROL

Recent Clinical Trials for DETROL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of California, San FranciscoPhase 4
Astellas Scientific & Medical Affairs, Inc.N/A
Astellas Pharma Global Development, Inc.Phase 4

See all DETROL clinical trials

Pharmacology for DETROL
Paragraph IV (Patent) Challenges for DETROL
Tradename Dosage Ingredient NDA Submissiondate
DETROL TABLET;ORAL tolterodine tartrate 020771

US Patents and Regulatory Information for DETROL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Upjohn DETROL tolterodine tartrate TABLET;ORAL 020771-001 Mar 25, 1998 AB RX Yes No   Start Trial   Start Trial   Start Trial
Upjohn DETROL LA tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 021228-002 Dec 22, 2000 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Upjohn DETROL LA tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 021228-001 Dec 22, 2000 AB RX Yes No   Start Trial   Start Trial   Start Trial
Upjohn DETROL LA tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 021228-002 Dec 22, 2000 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Upjohn DETROL tolterodine tartrate TABLET;ORAL 020771-002 Mar 25, 1998 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for DETROL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Upjohn DETROL tolterodine tartrate TABLET;ORAL 020771-001 Mar 25, 1998   Start Trial   Start Trial
Upjohn DETROL tolterodine tartrate TABLET;ORAL 020771-002 Mar 25, 1998   Start Trial   Start Trial
Upjohn DETROL tolterodine tartrate TABLET;ORAL 020771-002 Mar 25, 1998   Start Trial   Start Trial
Upjohn DETROL tolterodine tartrate TABLET;ORAL 020771-002 Mar 25, 1998   Start Trial   Start Trial
Upjohn DETROL tolterodine tartrate TABLET;ORAL 020771-001 Mar 25, 1998   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Supplementary Protection Certificates for DETROL

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0325571 1998C0031 Belgium   Start Trial PRODUCT NAME: TOLTERODINI-L-TARTRAS (=TOLTERODINUM); NATL REGISTRATION NO/DATE: 277 IS 301 F 3 19980309; FIRST REGISTRATION: SE 13475 19970905
0325571 SPC/GB98/027 United Kingdom   Start Trial PRODUCT NAME: TOLTERODINE OPTIONALLY IN THE FORM OF PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTERED: SE 13475 19970905; SE 13476 19970905; UK 00032/0222 19980203; UK 00032/0223 19980203
0325571 21/1998 Austria   Start Trial PRODUCT NAME: TOLTERODIN, SEINE SALZE, RACEMATE UND ENANTIOMERE; NAT. REGISTRATION NO/DATE: 1-22389 UND 1-22390 19980210; FIRST REGISTRATION: SE 13475 UND 13476 19970905
0325571 C980020 Netherlands   Start Trial PRODUCT NAME: TOLTERODINE, DESGEWENST IN DE VORM VAN EEN ZOUT MET EEN FYSIOLO GISCH ACCEPTABEL ZUUR, IN HET BIJZONDER TOLTERODINE L-TARTRAAT; NAT. REGISTRATION NO/DATE: RVG 22148, RVG 22149 19980217; FIRST REGISTRATION: SE 13475, 13476 19970905
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Medtronic
Express Scripts
Boehringer Ingelheim
Mallinckrodt
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.